-
Niva Bupa Health
82.00 61.01(%) -
Reliance Power
62.80 60.50(%) -
Max Healthcare
1,156.00 1,227.50(%) -
Mazagon Dock
3,380.35 1,200.00(%) -
Garden Reach Sh.
2,875.00 1,148.10(%) -
Suzlon Energy
73.44 86.04(%) -
Yes Bank
22.86 27.41(%) -
St Bk of India
818.50 912.10(%) -
Inox Wind
189.50 124.35(%) -
Eternal Ltd
243.00 304.50(%) -
Reliance Infra.
346.80 350.90(%) -
Cochin Shipyard
1,900.55 1,180.45(%) -
SG Finserve
445.95 546.00(%) -
Bharat Dynamics
1,965.00 897.15(%) -
Bank of Maha
57.80 73.50(%) -
MMTC
77.42 42.55(%) -
Data Pattern
2,972.00 3,654.75(%) -
Reliance Industr
1,395.90 1,115.55(%) -
NBCC
127.25 139.83(%) -
Kotak Mah. Bank
2,051.30 1,602.20(%)
- Overview
- Key Ratios
- Financials
- Shareholding
- Company Info
- Peer Comparison
- Overview
- Key Ratios
- Financials
- Shareholding
- Company Info
- Peer Comparison
RPG Life Sciences Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln
- Goenka R P
- BSE Code : 29175.0
- ISIN : INE105J01010
-
Today’s Low
2,141.20 -
Today’s High
2,189.70

-
Open
2,172.00 -
Perv Close
2,158.90 -
52W Low
1,381.00 -
52W High
2,974.95
Key Indicators
-
P/E(TTM)
30.54
-
Mar.Cap (₹Cr.)
3,607.49
-
Div & Yield %
1.10
-
Book Value(₹)
320.78
-
Debt-Equity Ratio
1.03
-
AGM Date
30-May-2025
-
EPS
71.51
-
P/E Ratio
30.54
Financials Ratios
-
Debt-Equity Ratio
-
-
Mar.Cap (₹Cr.)
3,607.49
-
RONW (%)
-
-
ROCE (%)
-
Score Board
-
Equity (₹ in Cr.)
13.23
-
BV (₹)
320.80
-
Sales( ₹ in Cr.)
653.43
-
NP (in Cr.)
118.26
-
NP Var(%)
36.0
-
Div%
300.0
-
CPS (₹)
84.50
-
EPS (₹)
71.50
-
Traded Value (₹ in Lakhs)
3,611.54
-
52 Week High
2,974.95
-
52 Week Low
1,381.00
-
Price BSE
2184.0
-
Price NSE
2,181.00
-
Market Capital( in Cr.)
3,611.54
-
P/C Ratio
25.90
-
P/E Ratio
30.50
-
Price Vs.BV
71.50
-
29-Apr-2025( 11:35)
Hot Pursuit - RPG L... - <P> Net sales rose by 12.7% ye...
-
29-Apr-2025( 09:35)
Corporate News - Board... - RPG Life Sciences announced th...
-
29-Apr-2025( 09:35)
Corporate News - Board... - RPG Life Sciences announced th...
-
29-Apr-2025( 07:35)
Results - Announcements - RPG L... - Net profit of RPG Life Science...
Navigate The Market With Confidence
Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions
Financials
All Values are in (₹Cr)Particulars(INCOME) | 2024 Mar | 2023 Mar | 2022 Mar | 2021 Mar | 2020 Mar | 2019 Mar |
---|---|---|---|---|---|---|
INCOME : | ||||||
Sales Turnover | 582.05 | 512.81 | 440.16 | 389.14 | 375.57 | 330.16 |
Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Sales | 582.05 | 512.81 | 440.16 | 389.14 | 375.57 | 330.16 |
Other Income | 7.21 | 4.80 | 2.99 | 0.91 | 0.73 | 0.80 |
Stock Adjustments | -2.70 | 7.30 | 25.21 | 5.01 | 5.98 | -13.71 |
Total Income | 586.56 | 524.91 | 468.36 | 395.06 | 382.28 | 317.25 |
EXPENDITURE : | ||||||
Raw Materials | 181.83 | 178.17 | 167.03 | 136.11 | 133.74 | 96.33 |
Power and Fuel Cost | 14.36 | 13.65 | 12.69 | 11.27 | 11.54 | 10.38 |
Employee Cost | 132.15 | 117.06 | 99.97 | 94.66 | 90.97 | 89.93 |
Other Manufacturing Expenses | 26.07 | 21.60 | 22.61 | 18.48 | 13.72 | 14.45 |
Selling and Administration Expenses | 80.47 | 73.63 | 67.07 | 58.40 | 56.84 | 59.43 |
Miscellaneous Expenses | 15.33 | 12.47 | 8.75 | 4.30 | 19.90 | 11.50 |
Employee Benefit Expenses | 132.15 | 117.06 | 99.97 | 94.66 | 90.97 | 89.93 |
Less: Preoperative Expenditure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Total Expenses | 450.21 | 416.58 | 378.12 | 323.22 | 326.71 | 282.02 |
Operating Profit | 136.35 | 108.33 | 90.24 | 71.84 | 55.57 | 35.23 |
Interest | 1.44 | 1.15 | 1.41 | 1.79 | 2.76 | 4.86 |
Gross Profit | 134.91 | 107.18 | 88.83 | 70.05 | 52.81 | 30.37 |
Depreciation | 17.07 | 15.50 | 15.66 | 16.47 | 16.36 | 15.32 |
Profit Before Tax | 117.84 | 91.68 | 73.17 | 53.58 | 36.45 | 15.05 |
Current Tax | 32.54 | 24.35 | 22.76 | 17.15 | 10.10 | 2.84 |
Fringe Benefit tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Deferred Tax | -2.36 | -0.31 | -1.07 | -3.57 | -2.66 | 1.40 |
Reported Net Profit | 87.66 | 67.64 | 51.48 | 40.00 | 29.01 | 10.81 |
Extraordinary Items | 0.77 | -0.57 | 0.61 | -0.01 | -3.93 | -0.04 |
Adjusted Net Profit | 86.89 | 68.21 | 50.87 | 40.01 | 32.94 | 10.85 |
Adjustment below Net Profit | -0.56 | 0.07 | -0.25 | -0.12 | -0.17 | -0.27 |
P & L Balance brought forward | 251.23 | 199.40 | 160.08 | 120.20 | 104.13 | 98.38 |
Statutory Appropriations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Appropriations | 19.85 | 15.88 | 11.91 | 0.00 | 12.77 | 4.79 |
P & L Balance carried down | 318.48 | 251.23 | 199.40 | 160.08 | 120.20 | 104.13 |
Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Preference Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Equity Dividend (%) | 200.00 | 150.00 | 120.00 | 90.00 | 50.00 | 30.00 |
Dividend Per Share(Rs) | 16.00 | 12.00 | 9.60 | 7.20 | 4.00 | 2.40 |
Earnings Per Share-Unit Curr | 53.01 | 40.90 | 31.13 | 24.19 | 17.54 | 6.54 |
Earnings Per Share(Adj)-Unit Curr | 53.01 | 40.90 | 31.13 | 24.19 | 17.54 | 6.54 |
Book Value | 226.67 | 186.00 | 154.66 | 130.88 | 106.77 | 97.05 |
Book Value(Adj)-Unit Curr | 226.67 | 186.00 | 154.66 | 130.88 | 106.77 | 97.05 |